Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,530
datasets available to search
ShareScore release 0.9.0
Dataset results
3,530 results for “Non-small cell lung cancer”
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00480025. IPD Sharing: YES. Countries: 34. Publications: 3.
ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02523469. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01104155. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00193453. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epi
ClinicalTrials.gov study NCT04538664. IPD Sharing: YES. Countries: 26. Publications: 3.
Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01026844. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02186847. IPD Sharing: Not stated. Countries: 3. Publications: 1.
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00445848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
ClinicalTrials.gov study NCT01355497. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02250326. IPD Sharing: Not stated. Countries: 7. Publications: 32.
Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01459497. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Merestinib In Non-Small Cell Lung Cancer And Solid Tumors
ClinicalTrials.gov study NCT02920996. IPD Sharing: NO. Countries: 1. Publications: 1.
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00367601. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00949910. IPD Sharing: Not stated. Countries: 51. Publications: 2.
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
ClinicalTrials.gov study NCT00257608. IPD Sharing: Not stated. Countries: 17. Publications: 1.
Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02855281. IPD Sharing: NO. Countries: 1. Publications: 1.
BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00411632. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET
ClinicalTrials.gov study NCT02544633. IPD Sharing: NO. Countries: 9. Publications: 2.
Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03794544. IPD Sharing: YES. Countries: 7. Publications: 1.
Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression F
ClinicalTrials.gov study NCT00993499. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.